REFERENCES
1. Bornstein S.R., Rubino F., Khunti K., Mingrone G., Hopkins D., Birkenfeld A.L., et al. Practical recommendations for the management of diabetes in patients with COVID-19. Lancet Diabetes Endocrinol. 2020; 8: 546-50.
2. Guo L., Shi Z., Zhang Y., Wang C., Do Vale Moreira N.C., Zuo H., et al. Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: a meta-analysis. Diabetes Res Clin Pract. 2020; 166: 108346.
3. Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T., Davidson K.W., et al.; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area. JAMA. 2020; 323: 2052-9.
4. Epidemiology Working Group for NCIP Epidemic Response, Chinese Center for Disease Control and Prevention. [The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China]. Zhonghua Liu Xing Bing Xue Za Zhi. 2020; 41: 145-51.
5. Shang J., Wang Q., Zhang H., Wang X., Wan J., Yan Y., et al. The relationship between diabetes mellitus and COVID-19 prognosis: a retrospective cohort study in Wuhan, China. Am J Med. 2020. DOI: https://doi.org/10.1016/j.am-jmed.2020.05.033
6. Wang D., Hu B., Hu C., Zhu F., Liu X., Zhang J., et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China. JAMA. 2020; 323: 1061-9.
7. Zhu L, She Z.G., Cheng X., Qin J.J., Zhang X.J., Cai J., et al. Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes. Cell Metab. 2020; 31: 1068-77e3.
8. Gupta R., Ghosh A., Singh A.K., Misra A. Clinical considerations for patients with diabetes in times of COVID-19 epidemic. Diabetes Metab Syndr. 2020; 14: 211-2.
9. Kosinski C., Zanchi A., Wojtusciszyn A. [Diabetes and COVID-19 infection]. Rev Med Suisse. 2020; 16: 939-43.
10. McDonnell M.E., Umpierrez G.E. Insulin therapy for the management of hyperglycemia in hospitalized patients. Endocrinol Metab Clin North Am. 2012; 41 (1): 175-201.
11. Umpierrez G., Hellman R., Korytkowski M.T., et al. Management of hyperglycemia in hospitalized patients in non-critical care setting: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2012; 97 (1): 16-38.
12. Moghissi E.S., Korytkowski M.T., Dinardo M.M., et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. Diabetes Care. 2009; 32 (6): 1119-31.
13. Fadel R., Morrison A.R., Vahia A., et al. Early short course corticosteroids in hospitalized patients with COVID-19. Clin Infect Dis. 2020; 71 (16): 2114-20. DOI: https://doi.org/10.1093/cid/ciaa601
14. Sardu C., D’Onofrio N., Balestrieri M.L., Barbieri M., Rizzo M.R., et al. Outcomes in patients with hyperglycemia affected by COVID-19: can we do more on glycemic control? Diabetes Care. 2020; 43 (7): 1408-15. DOI: https://doi.org/10.2337/dc20-0723
15. Chen Y., Yang D., Cheng B., Chen J., Peng A., et al. Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication. Diabetes Care. 2020; 43 (7): 1399-407 DOI: https://doi.org/10.2337/dc20-0660
16. Shestakova M.V., Vikulova O.K., Isakov M.A., Dedov I.I. Diabetes and COVID-19: analysis of the clinical outcomes according to the data of the Russian diabetes registry. Problemy endokrinologii [Problems of Endocrinology]. 2020; 66 (1): 35-46. DOI: https://doi.org/10.14341/probl12458 (in Russian)
17. Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: summary of a report of 72314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020; 323 (13): 1239. DOI: https://doi.org/10.1001/jama.2020.2648
18. Wu L, Girgis C.M., Cheung N.W. COVID-19 and diabetes: Insulin requirements parallel illness severity in critically unwell patients. Clin Endocrinol (Oxf). 2020; 93 (4): 390-93. DOI: https://doi.org/10.1111/cen.14288